PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD1A 2,739 Target Disease Carcinoma 433,099 146 0.00 -0.97 0.05 0.57
Alcohol Dehydrogenase 8,492 Target Disease Carcinoma 433,099 73 0.00 -1.00 0.01 0.52
CD68 6,424 Target Disease Carcinoma 433,099 448 0.01 -0.96 0.07 0.58
ATAC 239 Target Disease Carcinoma 433,099 8 0.00 -0.98 0.03 0.54
CNTF 1,613 Target Disease Carcinoma 433,099 7 0.00 -1.00 0.00 0.50
Adenosine A3 Receptor 164 Target Disease Carcinoma 433,099 2 0.00 -0.99 0.01 0.52
Androgen Receptor 12,918 Target Disease Carcinoma 433,099 928 0.01 -0.96 0.07 0.59
Endostatin 1,599 Target Disease Carcinoma 433,099 211 0.01 -0.93 0.13 0.59
Alpha-2a Adrenergic Receptor 188 Target Disease Carcinoma 433,099 4 0.00 -0.99 0.02 0.53
Myeloperoxidase 16,181 Target Disease Carcinoma 433,099 84 0.00 -1.00 0.01 0.51
BD2 76 Target Disease Carcinoma 433,099 2 0.00 -0.99 0.03 0.53
ACRP30 102 Target Disease Carcinoma 433,099 1 0.00 -1.00 0.01 0.52
Angiostatin K1-3 17 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Disease Carcinoma 433,099 144 0.00 -0.99 0.02 0.55
Estrogen Receptor Beta 1,924 Target Disease Carcinoma 433,099 100 0.00 -0.97 0.05 0.56
Glucocorticoid Receptor 10,306 Target Disease Carcinoma 433,099 134 0.00 -0.99 0.01 0.53
Adenosine A1 Receptor 1,432 Target Disease Carcinoma 433,099 5 0.00 -1.00 0.00 0.50
CCL19 658 Target Disease Carcinoma 433,099 29 0.00 -0.98 0.04 0.55
CXCL16 341 Target Disease Carcinoma 433,099 19 0.00 -0.97 0.06 0.56
BLK 255 Target Disease Carcinoma 433,099 3 0.00 -0.99 0.01 0.52
CD4 112,219 Target Disease Carcinoma 433,099 1,988 0.01 -0.99 0.02 0.56
DDR2 194 Target Disease Carcinoma 433,099 21 0.00 -0.94 0.11 0.57
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Carcinoma 433,099 11 0.00 -0.98 0.05 0.55
High Affinity Nerve Growth Factor Receptor 47 Target Disease Carcinoma 433,099 1 0.00 -0.99 0.02 0.53
CCL7 274 Target Disease Carcinoma 433,099 2 0.00 -1.00 0.01 0.51
ADRBK2 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56
ApoE2 517 Target Disease Carcinoma 433,099 1 0.00 -1.00 0.00 0.48
Collagenase-3 367 Target Disease Carcinoma 433,099 27 0.00 -0.96 0.07 0.56
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
Artemin 184 Target Disease Carcinoma 433,099 17 0.00 -0.95 0.09 0.57
Complement Component C3c 15 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.07 0.55
Ns3 3,189 Target Disease Carcinoma 433,099 156 0.00 -0.98 0.05 0.57
CD62L/L-Selectin 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56
Retinoic Acid Receptor Gamma-1 6 Target Disease Carcinoma 433,099 1 0.00 -0.91 0.17 0.56
D4-GDI 35 Target Disease Carcinoma 433,099 1 0.00 -0.99 0.03 0.53
CD22 1,591 Target Disease Infection 766,637 45 0.00 -0.99 0.03 0.53
Epidermal Growth Factor Receptor 24,772 Target Disease Infection 766,637 332 0.00 -0.99 0.01 0.52
Penicillin Binding Protein 3 162 Target Disease Infection 766,637 6 0.00 -0.98 0.04 0.53
APOH 110 Target Disease Infection 766,637 4 0.00 -0.98 0.04 0.53
CD1A 2,739 Target Disease Infection 766,637 240 0.01 -0.96 0.09 0.57
Alcohol Dehydrogenase 8,492 Target Disease Infection 766,637 67 0.00 -1.00 0.01 0.50
CD68 6,424 Target Disease Infection 766,637 425 0.01 -0.97 0.07 0.56
CNTF 1,613 Target Disease Infection 766,637 21 0.00 -0.99 0.01 0.51
Adenosine A3 Receptor 164 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.50
B-R1 90 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
Androgen Receptor 12,918 Target Disease Infection 766,637 52 0.00 -1.00 0.00 0.48
Endostatin 1,599 Target Disease Infection 766,637 26 0.00 -0.99 0.02 0.52
Myeloperoxidase 16,181 Target Disease Infection 766,637 896 0.01 -0.97 0.06 0.56
BD2 76 Target Disease Infection 766,637 4 0.00 -0.97 0.05 0.54